An overview on age related macular degeneration and recent advances in its management
Age-related macular degeneration (AMD) is a condition characterized, in the early stages, by slow development and progression, absence of symptoms over a number of years, and extensive retinal deposits called drusen, often associated with pigmentary abnormalities (early AMD).There is strong and c...
Main Authors: | SOBIA N., SARA F., AYESHA F. |
---|---|
Format: | Article |
Language: | English |
Published: |
Phytochemistry & Organic Synthesis Laboratory
2014-03-01
|
Series: | PhytoChem & BioSub Journal |
Subjects: | |
Online Access: | https://drive.google.com/file/d/0B8ZU6DpsSi6URGNIX1dmRFVTXzQ/view?usp=sharing |
Similar Items
-
Comparison of bevacizumab and ranibizumab in age-related macular degeneration:a systematic review and meta-analysis
by: Xiao-Yu Zhang, et al.
Published: (2014-04-01) -
Anti-VEGF agents in the treatment of diabetic macular edema
by: Vladimir Iosifovich Konenkov, et al.
Published: (2013-12-01) -
Comparison of Ranibizumab and Pegabtanib Sodium Monotherapies in Terms of Rates of Stabilization After the First Three Doses
by: Nilüfer Koçak, et al.
Published: (2012-05-01) -
The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice
by: Hussain Nazimul, et al.
Published: (2007-01-01) -
Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
by: Laura García-Quintanilla, et al.
Published: (2019-07-01)